T1	Participants 470 512	A total of 1195 patients in the LIFE-study
T2	Participants 564 572	patients
T3	Participants 651 659	patients
T4	Participants 792 800	Patients
T5	Participants 1006 1031	losartan-treated patients
T6	Participants 1036 1061	atenolol-treated patients
T7	Participants 1110 1122	103 patients
T8	Participants 1155 1176	139 assigned atenolol
T9	Participants 1120 1140	ts assigned losartan
